My lab is pleased to feature the MARS photon-counting micro-CT in our research and development of targeted nanoparticle imaging probes for contrast-enhanced CT and quantitative molecular imaging with spectral (multi-energy) CT.
The MARS system is the only product on the market that enables my cutting-edge research to move forward as fast as possible. We are able to transition seamlessly between translation studies spanning from imaging phantoms to in vivo murine models.
The MARS scanner in UOC has provided an opportunity to Christchurch researchers to be at the forefront of developing new clinical applications for photon counting CT modality.
By using this novel system, my research group has produced remarkable results on many aspects of the medical applications of spectral CT imaging such as molecular imaging of tumours, drug delivery, atherosclerosis and bone quality
My lab is blessed to have the latest MARS photon-counting micro-CT scanner. This spectral (multi-energy) CT will be used for preclinical research and development and translation to clinical applications such as targeted nanoparticle imaging and quantitative molecular imaging.
The MARS system is the only product in the market that enables important investigations with photon-counting detectors and redefines the state of the art.
The MARS scanner gives us the ability to rapidly and non-destructively characterise atherosclerotic plaques at high resolutions.
Without this technology we would be unable to compare the biochemistry of the plaques and understand the effect of calcification on cell behaviour.